|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | c/o Brian T. Hildreth |
Address2 | 455 Capitol Mall, Suite 600 |
City | Sacramento |
State | CA |
Zip Code | 95814 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 40006052-12
|
||||||||
|
6. House ID# 397410000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brian Hildreth |
Date | 1/20/2016 12:45:12 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2, The Medicare Access and Childrens Health Insurance Program Reauthorization Act
H.R. 6, The 21st Century CURES Act (Upton/DeGette)
H.R. 2568 The Fair Medical Audits Act (Holding)
H.R. 3077 Telemedicine Act (Nunes)
H.R. 5380 Medicare Telehealth Parity Act (Thompson/Eshoo)
H.R. 2725 21st Century Care for Military and Veterans Act (Peters)
H.R. 3750 Telehealth Modernization Act (Matsui)
H.R. 1925 Congressional Gold Medal to Dr. Ernie Bodai (Speier)
H.R. 3309 (Ellmers) The Further Flexibility in HIT Reporting and Advancing Interoperability Act - FLEX IT 2 ACT
S. 2141 (Cassidy/Whitehouse) The Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015
S. 2425 Patient Access and Medicare Protection Act
H.R. 2568 (Holding) The Fair Medical Audits Act of 2015
H.R. 2247 (Black) The ICD-10 Act
H.R. 6 (Upton/DeGette) The 21th Century CURES Act
H.R. 3081 (Nunes/Pallone) The Tele-Med Act of 2015
H.R. 2029 The Consolidated Appropriations Act of 2016. FY 2016 Omnibus Appropriations Bill.
H.R. 2725 (Peters) 21st Century Care for Military and Veterans Act
Medicare Budget Sequestration Cuts
Medicare Graduate Medical Education Funding
ICD-10 Implementation for Medicare and Medicaid
Medicaid Recoupment for Radiological Service Payments
The Medicare Access and Childrens Health Insurance Program Reauthorization Act (MACRA-H.R. 2) Implementation
Regulation CMS 33311-P: Medicare and Medicaid Programs Electronic Health Record Incentive Program- Modifications to Meaningful Use 2015-2017
Graduate Medical Education Funding
CMS-3310-P Medicare & Medicaid Program; Electronic Health Records Incentive Program; Stage 3
CMS 3311-P Medicare & Medicaid Program; Medicare and Medicaid Program; Electronic Health
Record Incentive Program-Modifications to Meaningful Use Stage 2 in 2015-2017.
CMS Regulations related to EHR Meaningful Use Stage 2 and Stage 3
Meaningful Use Stage 3 correspondence
ICD-10 Coding Implementation and Grace Period
Medicare and Medicaid Programs; Electronic Health Record Incentive Program Stage 3 and Modifications to Meaningful Use in 2015-2017. CMS 3310 and 3311-FC.
ICD-10 Diagnosis Coding Program.
CMS 2328-FC: Medicaid Program; Methods for Assuring Access to Covered Medicaid Services.
California Medicaid Waive
42 CFR Part 414: Request for Information. Implementation of Merit-Based Incentive Payment System, Promotion of Alternative Payment Models, and Incentive Payments for Participation in Eligible Alternative Payment Models. CMS 3321-NC.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
McNeil |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Public Service Loan Forgiveness Program (PSLF)
17. House(s) of Congress and Federal agencies Check if None
Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
McNeil |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Proposed 2016 Guidelines for Prescribing Opioids for Chronic Pain
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
McNeil |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |